Non-chemotherapy infusion codes targeted in latest CCI

Why This Topic Matters

CCI updates can change how claims are processed and whether certain combinations are eligible for separate payment or modifier-based override. Understanding the scope of the edits helps coding and reimbursement teams monitor affected services and recognize where policy changes may alter reporting or payment patterns.

Article Sections

1. Overview of the latest CCI update

   Summarizes the scope of the Version 11.2 update and the general categories of edits included. It also notes the effective date and the overall volume of additions and deletions.

2. New non-chemotherapy injection and infusion codes

   Discusses newly affected injection and infusion services and how they are grouped in the update. The section focuses on the broad impact of bundling across related services.

3. Evaluation and management and other bundled services

   Addresses how selected evaluation and management services are affected and contrasts them with other bundled code relationships. It also references changes involving related service categories.

4. Changes involving modifier overrides in surgical code families

   Reviews updates affecting whether modifiers may be used in connection with certain bundled surgical code combinations. The discussion is centered on broader family-level policy changes.

5. CCI Version 11.2 Scorecard

   Presents a summary table of additions, deletions, and mutually exclusive edit counts across major code ranges. It provides an at-a-glance view of the update’s overall distribution.